The improved understanding of mechanisms underlying the development of AD, and thus the identification of new treatment targets, has largely been driven by genetic studies. One of the most influential scientists in this area is the third keynote speaker at… Continue Reading →
The Alzheimer’s disease (AD) community has been shaken by disappointing clinical trials for treatments created to slow or stop disease progression. Nonetheless, there remain reasons for optimism based on an improved understanding of the pathophysiology and course of the disease… Continue Reading →
The 10th international conference on Clinical Trials in Alzheimer’s Disease (CTAD) welcomed some 1250 delegates to Boston, Massachusetts on Wednesday, November 1, 2017 for a meeting to discuss progress and disappointments in drug development for Alzheimer’s disease (AD). Moving Towards… Continue Reading →
© 2024 Aging-news